Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting

v2.4.1.9
Segment Reporting
 9 Months Ended
Mar. 31, 2015
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]
13.
Segment Reporting
 
As discussed above, iBio Brazil began operations in the first quarter of fiscal 2015. In accordance with FASB ASC 280, “Segment Reporting,” the Company discloses financial and descriptive information about its reportable geographic segments. Geographic segments are components of an enterprise about which separate financial information is available and regularly evaluated by the chief operating decision maker in deciding how to allocate resources and in assessing performance.
 
 
 
 
 
iBio
 
 
 
Three months ended March 31, 2015
 
iBio
 
Brazil
 
Total
 
 
 
 
 
 
 
 
 
Net revenues
 
$
349
 
$
-
 
$
349
 
Research and development expenses
 
 
815
 
 
-
 
 
815
 
General and administrative expenses
 
 
1,187
 
 
35
 
 
1,222
 
Operating loss
 
 
(1,653)
 
 
(35)
 
 
(1,688)
 
 
 
 
 
 
iBio
 
 
 
Nine months ended March 31, 2015
 
iBio
 
Brazil
 
Total
 
 
 
 
 
 
 
 
 
Net revenues
 
$
1,535
 
$
-
 
$
1,535
 
Research and development expenses
 
 
2,731
 
 
-
 
 
2,731
 
General and administrative expenses
 
 
3,488
 
 
86
 
 
3,574
 
Operating loss
 
 
(4,684)
 
 
(86)
 
 
(4,770)
 
Total assets
 
 
11,383
 
 
63
 
 
11,446